Kamila Valieva, a teen figure skater, has been the subject of a case referral by the World Anti-Doping Agency to the Court of Arbitration for Sport.
In the wake of Valieva being found to have “no fault or negligence” for a positive doping test, the Russian Anti-Doping Agency (Rusada) made this determination.
According to Wada, the decision was “in violation of the World Anti-Doping Code.”
For the 16-year-old, it is asking for a four-year ban.
When Valieva, then 15, tested positive for the illegal heart drug trimetazidine in December 2021, she failed a drug test.
Details of the outcome didn’t come to light until after she had won gold in the team competition at the Beijing Games in February 2022, when she made Olympic history by becoming the first woman to land a quadruple jump.
After a court lifted her temporary suspension, she was permitted to participate in the women’s singles competition.
She left the arena in tears, having dropped from first to fourth after a number of stumbles and falls.
Wada revealed the results of Rusada’s doping investigation into Valieva last month and expressed “concern” over the choice to uphold her innocence.
The Russian Olympic Committee figure skater Kamila Valieva’s case has been thoroughly examined by the World Anti-Doping Agency (Wada), according to Wada.
“Wada has exercised its right to file an appeal with the Court of Arbitration for Sport because it believes that the Russian Anti-Doping Agency’s determination that the athlete had “no fault or negligence” in this case violates the World Anti-Doping Code.
“Wada is asking for a four-year period of ineligibility and the disqualification of all of the athlete’s results starting on December 25, 2021, the date the sample was collected.
“Wada will continue to push for this matter to proceed without further unnecessary delay,” the company said.